All News

The 17-member panel will hold 5 public meetings to review evidence before issuing its report. The last set of guidelines was published in 2008.

The citation from the World Economic Forum allows the digital behavioral health company to participate in the annual meeting of new champions.Some will also participate in the annual meeting in Davos, Switzerland.

When the topic of affordability of healthcare comes up, people usually mean the price of healthcare, but there is a difference, said Tomas Philipson, PhD, of the University of Chicago, at the ISPOR Annual Meeting.

What we're reading, June 29, 2016: CMS is considering changes to the proposed Medicare Part B demonstration; Senate Democrats block the GOP's Zika funding bill; and a Bloomberg analysis shines light on the pricing practices of the pharmaceutical industry.

A newly formed data-sharing initiative, Oncology Precision Network (OPeN), is promising a boost to precision medicine via data access to several health systems and cancer patients in the nation.

Improved health literacy will help consumers understand plans and benefits so that they can make better decisions and Florida Blue has focused on experiential marketing where customers are engaged in community events, outreach programs, and educational sessions, explained Anne Jessup, senior director of digital channels at Florida Blue.

Maximizing the utility of technology platforms and making them meaningful to ensure quality cancer care was the underlying theme of Emerging Issues and Opportunities in Health Information Technology, a National Comprehensive Cancer Network Policy Summit.

Nearly one-third of American consumers report experiencing a steep increase over the last year in prices paid for drugs they routinely take, which is having a spillover effect on all phases of their lives.

A combination of sofosbuvir and velpatasvir (Epclusa) that is effective against all 6 major forms of the hepatitis C virus (HCV) has received the FDA’s consent to market.

What we're reading, June 28, 2016: Illinois approves Aetna-Humana merger; Harvard Pilgrim Health Care reaches value-based payment agreements with Novartis and Eli Lilly; and the Supreme Court struck down key aspects of the Texas abortion law.

Six former FDA commissioners participated in a discussion at the Aspen Ideas Festival on the challenges that the agency faces and whether it is well equipped to do its job.

The rising cost of drugs is a cause for concern among various stakeholders in healthcare, some of who worry that staying on the current trajectory will “break the bank,” said panelists during a session at the ISPOR Annual Meeting.

Identifying simple practices that hospices can implement to contribute to fewer future patient hospitalizations can not only save on hospitalization costs, but also benefit patient quality of life.

What we're reading, June 27, 2016: Blue Cross and Blue Shield of Minnesota is leaving the individual market; out-of-pocket costs for hospital visits grew 37% in 5 years; and a growing number of millennials are becoming caregivers for loved ones.

More than 58% of healthcare payers’ businesses have already shifted to full value-based reimbursement models, a 10% increase since 2014.

At the Pharmacy Quality Alliance's Annual Meeting, Kate Goodrich, MD, of CMS, and a group of experts discussed the government's move toward value-based care and the use of quality measures.

Prescription drug spending between 2014 and 2015 increased at a much higher rate among health exchange plans compared with commercial plans, Medicare, and Medicaid plans. Express Scripts highlighted 3 select trends that are having the biggest impact on plans.

This week in managed care, the top stories included House Republicans' new plan to repeal and replace the Affordable Care Act, new funding from HHS to help small practices follow the Medicare Access and CHIP Reauthorization Act, and the Supreme Court rules on a patent lawsuit that impacts pharmaceutical companies.

Despite recommendations and the passage of legislation, there is little evidence that the quality of behavioral health has improved significantly over the last 10 years in the United States.

For African Americans in poor Mississippi counties, having diabetes and kidney disease in combination lead to cardiovascular death rates that were on par with underdeveloped nations.

Although physiologic vital signs tell healthcare providers a great deal about their patients’ health status, providers need, but don’t have ready access to, information about their patients’ neighborhoods.

This week's takedown shows that the fraud prevention and enforcement efforts that began nearly a decade ago are bearing fruit, including the change to predictive modeling to spot suspicious billing in Medicare.

Exposure of patients to the dangers of certain diagnostic equipment can have unwanted long-term effects, which healthcare providers may be underestimating, according to research conducted at the University of Saskatchewan.

What we're reading, June 24, 2016: Britain's decision to leave the European Union will impact drug regulation; Supreme Court decision derails California proposal to allow illegal immigrants to buy health insurance; and lawmakers look to reduce exclusivity period for biologics.

HHS and the Department of Justice announced a nationwide sweep led by the Medicare Fraud Strike Force resulting in charges against 301 individuals for their alleged participation in healthcare fraud schemes involving $900 million in false billings.

An appellate panel found that a group of hospitals could not have information that Horizon withheld during discovery in 2 breach of contract suits related to its OMNIA tiered health plan. An attorney for 1 group of those hospitals said it will appeal because consumers and providers need to know how the tiered health network was created.

A report developed by Avalere Health, based on a survey that the company conducted among health plans in 2015, states that a majority of health plans want to sign outcomes-based contracts with biopharmaceutical companies, especially for oncology and hepatitis C drugs.

A new study in the New England Journal of Medicine has established that, at least in the case of lymphoma, a positron emission tomography (PET) scan can spare the patients serious side effects of chemotherapy.

The study comes as regulators put increased emphasis on long-term cardiovascular outcomes trials to ensure safety of diabetes and obesity therapies. The American Journal of Managed Care recently convened an expert panel on the topic.